Eric Sciorilli | executive |
Terrie Curran | executive |
Martin Gilligan | executive |
Molly Henderson | executive |
Annabel Samimy | analyst |
Joseph Stringer | analyst |
Yatin Suneja | analyst |
Kyuwon Choi | analyst |
Chase Knickerbocker | analyst |
Matthew Caufield | analyst |
Hello, and welcome to Phathom Pharmaceuticals second quarter 2024 earnings results call. [Operator Instructions] Please be advised that today's conference is being recorded. With that, I would like to turn the conference over to Eric Sciorilli, Phathom's Head of Investor Relations. Please go ahead.
Thank you, operator. Hello, everyone, and thank you for joining us this morning to discuss Phathom's second quarter 2024 results. This morning's presentation will include remarks from Terrie Curran, our President and CEO; Martin Gilligan, our Chief Commercial Officer; and Molly Henderson, our Chief Financial Officer.